Monopar Therapeutics Inc. Common Stock (MNPR) is a publicly traded Healthcare sector company. As of May 20, 2026, MNPR trades at $57.95 with a market cap of $376.82M and a P/E ratio of -29.81. MNPR moved -1.64% today. Year to date, MNPR is -16.38%; over the trailing twelve months it is +49.59%. Its 52-week range spans $4.50 to $105.00. Analyst consensus is strong buy with an average price target of $113.00. Rallies surfaces MNPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own MNPR include Point72 Asset. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Monopar Therapeutics Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $57.95 |
| Market Cap | $376.82M |
| P/E Ratio | -29.81 |
| EPS | $-1.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $105.00 |
| 52-Week Low | $4.50 |
| Volume | 235.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.72M |
| Gross Margin | 0.00% |
7 analysts cover MNPR: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $113.00.